Acute Transverse Myelitis Associated with Buserelin Use during IVF. (28th March 2013)

• Record Type: Journal Article
• Authors: Alleemudder, Djavid I.; Sadek, Khaled; Fountain, Shaun; Davies, Sallie
• Other Names: Canterino J. C. Academic Editor.; Dafopoulos K. Academic Editor.; Deffieux X. Academic Editor.; Furuhashi M. Academic Editor.; Hochner-Celnikier D. Academic Editor.; Murta E. F. C. Academic Editor.; Origoni M. Academic Editor.; Osmanagaoglu M. A. Academic Editor.; Porpora M. G. Academic Editor.
• Is Part Of: Case reports in obstetrics and gynecology. Volume 2013(2013)
• Publication Date: 2013-03-28
• Subjects: Obstetrics -- Periodicals; Gynecology -- Periodicals; Generative organs, Female -- Diseases -- Periodicals; Obstetrics; Gynecology; Genital Diseases, Female; Generative organs, Female -- Diseases; Gynecology; Obstetrics; Electronic journals; Periodicals; Periodicals; 618
• DOI: 10.1155/2013/386765
• Languages: English
• ISSNs: 2090-6684

Abstract

Abstract : A healthy woman undergoing in vitro fertilization (IVF) developed acute transverse myelitis (ATM) following the use of Buserelin. ATM has a multifactorial etiology and may develop as a result of the activation of immune responses. Infectious agents have been postulated as possible triggers of an immune response (Sá, 2009). Gonadotropin-releasing agonists may have a similar role and trigger the acceleration of preexisting disease by the activation of immune responses (Ho et al., 1995, and Umesaki et al., 1999).